Peer-reviewedCC BY-NCAnnals of coloproctology
Neoadjuvant chemotherapy in locally advanced colon cancer: lessons from the NeoCol trial and the limits of anatomical risk stratification.
- 1Department of General Surgery, Wexham Park Hospital, Frimley Health NHS Foundation Trust, Slough, UK.
Related
- Relative change rate of neutrophil-to-albumin ratio (ΔNAR) during neoadjuvant chemotherapy predicts axillary pathological complete response in locally advanced breast cancer
- Efficacy and safety of neoadjuvant chemotherapy with toripalimab in locally advanced nasopharyngeal carcinoma: a phase II trial and biological correlate analysis
- Multimodal prediction of neoadjuvant chemotherapy response in locally advanced gastric cancer: a multicenter cohort study
- Analysis of Laryngoscopic Image Differences in Different Responses to Neoadjuvant Immunotherapy Combined With Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma.
- Evaluation of the efficacy and safety of different cycles of neoadjuvant chemotherapy combined with immunotherapy in locally advanced esophageal squamous cell carcinoma: a multi-center, real-world study.
BibTeX
@article{alkashty2026neoadjuvant,
title = {{Neoadjuvant chemotherapy in locally advanced colon cancer: lessons from the NeoCol trial and the limits of anatomical risk stratification.}},
author = {Mohamed Alkashty},
journal = {Annals of coloproctology},
year = {2026},
month = oct,
doi = {10.3393/ac.2026.00703.0100},
url = {https://europepmc.org/article/MED/42958785},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Neoadjuvant chemotherapy in locally advanced colon cancer: lessons from the NeoCol trial and the limits of anatomical risk stratification.
AU - Mohamed Alkashty
PY - 2026
DA - 2026/10/15
JO - Annals of coloproctology
DO - 10.3393/ac.2026.00703.0100
UR - https://europepmc.org/article/MED/42958785
SN - 2287-9714
SN - 2287-9722
ER -